benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide

C161H173F6N27O28 — CID 157064094

About benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide

benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide (PubChem CID 157064094) has the molecular formula C161H173F6N27O28 and a molecular weight of 3048.30 g/mol. Its IUPAC name is benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide.

Molecular Properties

• Compound Name: benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide
• PubChem CID: 157064094
• Molecular Formula: C161H173F6N27O28
• Molecular Weight: 3048.30 g/mol
• Exact Mass: 3046.28
• IUPAC Name: benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide
• SMILES: CC(C)C(NC(=O)CN1C(=O)C(c2ccccc2)N(CCN2CCOCC2)C1=O)C(=O)c1noc(Cc2cccc(C(F)(F)F)c2)n1.CC(C)[C@H](NC(=O)CN1C(=O)CN(Cc2ccccc2)C1=O)C(=O)c1noc(Cc2cccc(C(F)(F)F)c2)n1.Cc1cccc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)C(c4ccccc4)N(CCN4CCOCC4)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)N(Cc4ccccc4)C(=O)[C@@H]3Cc3ccccc3)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)CN(C(=O)OCc4ccccc4)C[C@H]3Cc3ccccc3)C(C)C)o2)c1
• InChI: InChI=1S/C36H39N5O6.C34H35N5O5.C32H35F3N6O6.C32H38N6O6.C27H26F3N5O5/c1-24(2)33(34(44)35-39-38-31(47-35)19-28-16-10-11-25(3)17-28)37-30(42)21-41-29(18-26-12-6-4-7-13-26)20-40(22-32(41)43)36(45)46-23-27-14-8-5-9-15-27;1-22(2)30(31(41)32-37-36-29(44-32)19-26-16-10-11-23(3)17-26)35-28(40)21-38-27(18-24-12-6-4-7-13-24)33(42)39(34(38)43)20-25-14-8-5-9-15-25;1-20(2)26(28(43)29-37-25(47-38-29)18-21-7-6-10-23(17-21)32(33,34)35)36-24(42)19-41-30(44)27(22-8-4-3-5-9-22)40(31(41)45)12-11-39-13-15-46-16-14-39;1-21(2)27(29(40)30-35-34-26(44-30)19-23-9-7-8-22(3)18-23)33-25(39)20-38-31(41)28(24-10-5-4-6-11-24)37(32(38)42)13-12-36-14-16-43-17-15-36;1-16(2)23(24(38)25-32-21(40-33-25)12-18-9-6-10-19(11-18)27(28,29)30)31-20(36)14-35-22(37)15-34(26(35)39)13-17-7-4-3-5-8-17/h4-17,24,29,33H,18-23H2,1-3H3,(H,37,42);4-17,22,27,30H,18-21H2,1-3H3,(H,35,40);3-10,17,20,26-27H,11-16,18-19H2,1-2H3,(H,36,42);4-11,18,21,27-28H,12-17,19-20H2,1-3H3,(H,33,39);3-11,16,23H,12-15H2,1-2H3,(H,31,36)/t29-,33+;27-,30?;;;23-/m10..0/s1
• InChIKey: ABRANORSRNIXBK-IZJGVFSKSA-N
• XLogP: 18.19
• TPSA: 662.72 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 40
• Rotatable Bonds: 58
• Heavy Atoms: 222
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3048.30
LogP ≤ 5	18.19
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	40

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'hydantoin', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide?

The IUPAC name of benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide (CID 157064094) is benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide.

What is the SMILES notation for benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide?

The canonical SMILES for benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide is CC(C)C(NC(=O)CN1C(=O)C(c2ccccc2)N(CCN2CCOCC2)C1=O)C(=O)c1noc(Cc2cccc(C(F)(F)F)c2)n1.CC(C)[C@H](NC(=O)CN1C(=O)CN(Cc2ccccc2)C1=O)C(=O)c1noc(Cc2cccc(C(F)(F)F)c2)n1.Cc1cccc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)C(c4ccccc4)N(CCN4CCOCC4)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)C(NC(=O)CN3C(=O)N(Cc4ccccc4)C(=O)[C@@H]3Cc3ccccc3)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)CN(C(=O)OCc4ccccc4)C[C@H]3Cc3ccccc3)C(C)C)o2)c1.

What is the InChIKey of benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide?

The InChIKey is ABRANORSRNIXBK-IZJGVFSKSA-N. The full InChI is InChI=1S/C36H39N5O6.C34H35N5O5.C32H35F3N6O6.C32H38N6O6.C27H26F3N5O5/c1-24(2)33(34(44)35-39-38-31(47-35)19-28-16-10-11-25(3)17-28)37-30(42)21-41-29(18-26-12-6-4-7-13-26)20-40(22-32(41)43)36(45)46-23-27-14-8-5-9-15-27;1-22(2)30(31(41)32-37-36-29(44-32)19-26-16-10-11-23(3)17-26)35-28(40)21-38-27(18-24-12-6-4-7-13-24)33(42)39(34(38)43)20-25-14-8-5-9-15-25;1-20(2)26(28(43)29-37-25(47-38-29)18-21-7-6-10-23(17-21)32(33,34)35)36-24(42)19-41-30(44)27(22-8-4-3-5-9-22)40(31(41)45)12-11-39-13-15-46-16-14-39;1-21(2)27(29(40)30-35-34-26(44-30)19-23-9-7-8-22(3)18-23)33-25(39)20-38-31(41)28(24-10-5-4-6-11-24)37(32(38)42)13-12-36-14-16-43-17-15-36;1-16(2)23(24(38)25-32-21(40-33-25)12-18-9-6-10-19(11-18)27(28,29)30)31-20(36)14-35-22(37)15-34(26(35)39)13-17-7-4-3-5-8-17/h4-17,24,29,33H,18-23H2,1-3H3,(H,37,42);4-17,22,27,30H,18-21H2,1-3H3,(H,35,40);3-10,17,20,26-27H,11-16,18-19H2,1-2H3,(H,36,42);4-11,18,21,27-28H,12-17,19-20H2,1-3H3,(H,33,39);3-11,16,23H,12-15H2,1-2H3,(H,31,36)/t29-,33+;27-,30?;;;23-/m10..0/s1.

What are the key properties of benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide?

benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide has a molecular weight of 3048.30 g/mol, XLogP of 18.19, 58 rotatable bonds, 5 hydrogen bond donors, and 40 hydrogen bond acceptors.

Where does this data come from?

All data for benzyl (3R)-3-benzyl-4-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-5-oxopiperazine-1-carboxylate;2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-N-[(2S)-3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]acetamide;2-[(5S)-3,5-dibenzyl-2,4-dioxoimidazolidin-1-yl]-N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N-[3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide;N-[3-methyl-1-oxo-1-[5-[[3-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-3-yl]butan-2-yl]-2-[3-(2-morpholin-4-ylethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]acetamide is sourced from PubChem (CID 157064094), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).